WESLEY S. MOORE, MD​

VASCULAR & ENDOVASCULAR SURGEON

2024 UCLA SVS Vascular Course

A Comprehensive Review and Update of
What’s New in Vascular and Endovascular Surgery
(Moore Course)

August 21-24, 20024
The Beverly Hilton
Beverly Hills, California

What’s New in Vascular and Endovascular Surgery
IN COLLABORATION WITH THE SOCIETY FOR VASCULAR SURGERY
svs society for vascular surgery
amedco
Joint Accreditation Statement
American Board of Surgery (ABS) MOC
Wesley Moore MD

WESLEY S. MOORE, M.D.

Professor and Chief, Emeritus
Division of Vascular Surgery
UCLA Medical Center

Practice limited to treatment of carotid artery disease and aortic aneurysm including the less invasive stent-graft repair.

Complete Series​

Moore’s Vascular and Endovascular Surgery: A Comprehensive Review 9th Edition

By Wesley Moore, MD

Using an easy-to-read, user-friendly format and hundreds of review questions that facilitate effective studying, Vascular and Endovascular Surgery: A Comprehensive Review, 9th Edition, contains the essential information you need for exam success and daily reference.

Dr. Wesley Moore and a team of international experts cover everything from foundational concepts to the latest developments in the field, with each specialist providing a complete summary of a particular area of expertise. Extensive updates throughout the text keep you current with all that’s new in this rapidly expanding field.

Vascular and Endovascular Surgery: A Comprehensive Review 9th Edition

CAROTID ARTERY STENOSIS WITHOUT SYMPTOMS

CAROTID ARTERY STENOSIS WITHOUT SYMPTOMS: UCLA
DIVISION OF VASCULAR AND ENDOVASCULAR SURGERY IS OFFERING PARTICIPATION IN A NEW CLINICAL TRIAL( CREST 2).

For further information call our clinical trials office at 310-206-1115

ANNOUNCEMENT

DIRECT CAROTID STENT ANGIOPLASTY WITH FLOW REVERSAL(TCAR)
A NEW AND SAFER APPROACH TO CAROTID ARTERY STENTING

By Wesley Moore, MD

I am pleased to announce that the Division of Vascular and Endovascular Surgery at UCLA has successfully completed a clinical trial and is now offering a new and less invasive approach to treatment of carotid artery disease as a means of stroke prevention. The traditional approach for managing disease of the carotid bifurcation has been carotid endarterectomy(CEA). This continues to be an excellent and proven treatment.

Prior attempts to provide a less invasive alternative to CEA have utilized carotid artery stenting via the femoral artery in the leg(CAS). Unfortunately clinical trials have shown that CAS carries twice the risk of stroke/death when compared to CEA. Several recent trials using the new approach of direct carotid stent angioplasty with temporary flow reversal(TCAR) have demonstrated results that are equally as good as CEA and have the advantage of being less invasive(see fig 1and animation). This has led to the approval of this procedure by the United States Food and Drug Administration(FDA).

DIRECT CAROTID STENT ANGIOPLASTY WITH FLOW REVERSAL(TCAR) A NEW AND SAFER APPROACH TO CAROTID ARTERY STENTING

Should you have a patient that you would like us to consider for this trial, please contact me or our study coordinator, Kathleen Land R.N. at 310-206-1115. We look forward to working with you.

Wesley S. Moore, M.D.
Professor and Chief, Emeritus
Division of Vascular Surgery, UCLA
310-825-9641

Scroll to Top